Publicaciones en colaboración con investigadores/as de National Institutes of Health (45)

2024

  1. A road map for the treatment of pediatric diffuse midline glioma

    Cancer Cell

2023

  1. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  2. MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells

    Journal of Hepatology, Vol. 78, Núm. 2, pp. 364-375

2021

  1. Exome-wide rare variant analysis in familial essential tremor

    Parkinsonism and Related Disorders, Vol. 82, pp. 109-116

  2. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2020

  1. EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Núm. 8, pp. 1885-1912

  2. Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. “Ears of the lynx” MRI sign is associated with SPG11 and SPG15 hereditary spastic paraplegia

    American Journal of Neuroradiology, Vol. 40, Núm. 1, pp. 199-203

2018

  1. Body mass index is negatively associated with telomere length: A collaborative cross-sectional meta-analysis of 87 observational studies

    American Journal of Clinical Nutrition, Vol. 108, Núm. 3, pp. 453-475

  2. Practitioner review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder

    Journal of Child Psychology and Psychiatry and Allied Disciplines, Vol. 59, Núm. 9, pp. 932-947

2017

  1. ACOX2 deficiency: An inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemia

    Journal of Hepatology, Vol. 66, Núm. 3, pp. 581-588

  2. Effect of the interaction between diet composition and the PPM1K genetic variant on insulin resistance and β cell function markers during weight loss: Results from the Nutrient Gene Interactions in Human Obesity: Implications for dietary guidelines (NUGENOB) randomized trial

    American Journal of Clinical Nutrition, Vol. 106, Núm. 3, pp. 902-908

  3. Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

    The Lancet, Vol. 390, Núm. 10103, pp. 1664-1675

  4. Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

    Science Translational Medicine, Vol. 8, Núm. 341

  2. Bile acids in physiology, pathology and pharmacology

    Current Drug Metabolism, Vol. 17, Núm. 1, pp. 4-29

  3. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis

    Proteomics, Vol. 16, Núm. 8, pp. 1280-1290

  4. International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment

    Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557

2015

  1. Convergent genetic and expression data implicate immunity in Alzheimer's disease

    Alzheimer's and Dementia, Vol. 11, Núm. 6, pp. 658-671

  2. Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT)

    Journal of Controlled Release, Vol. 216, pp. 93-102